Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Alpern

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
BMC Medical Education|July 17, 2016
Perceived barriers to success for resident physicians interested in immigrant and refugee healthJonathan D Alpern, Cynthia S Davey, John Song
The New England Journal of Medicine|May 19, 2016
Essential Medicines in the United States--Why Access Is DiminishingJonathan D Alpern, John Song, William M Stauffer
JAMA Network Open|April 17, 2023
Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical IndustryAileen S Ahiskali, Dimitri M Drekonja, Jonathan D Alpern
Open Forum Infectious Diseases|March 19, 2025
Characteristics of Clinics Offering Nontraditional Lyme Disease Therapies in Lyme Endemic States of the United StatesJason R Sakizadeh, Meghan K Rothenberger, Jonathan D Alpern
Plos Neglected Tropical Diseases|September 15, 2017
Access to benznidazole for Chagas disease in the United States-Cautious optimism?Jonathan D Alpern, Rogelio Lopez-Velez, William M Stauffer
The New England Journal of Medicine|November 13, 2014
High-cost generic drugs--implications for patients and policymakersJonathan D Alpern, William M Stauffer, Aaron S Kesselheim
The New England Journal of Medicine|February 12, 2015
High-cost generic drugs--implications for patients and policymakersAaron S Kesselheim, Jonathan D Alpern, William M Stauffer
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 3, 2022
Food and Drug Administration Approval of Artesunate for Severe Malaria: Enough to Achieve Best Practice?Christine M Thomas, William M Stauffer, Jonathan D Alpern
Annals of Internal Medicine|June 19, 2018
Hepatitis B Vaccination, Screening, and Linkage to CareJonathan D Alpern, Thomas M Leventhal, Nathan C Bahr
JAMA|August 8, 2020
COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides HyperinfectionWilliam M Stauffer, Jonathan D Alpern, Patricia F Walker
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
BMC Medical Education|July 17, 2016
Perceived barriers to success for resident physicians interested in immigrant and refugee healthJonathan D Alpern, Cynthia S Davey, John Song
The New England Journal of Medicine|May 19, 2016
Essential Medicines in the United States--Why Access Is DiminishingJonathan D Alpern, John Song, William M Stauffer
JAMA Network Open|April 17, 2023
Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical IndustryAileen S Ahiskali, Dimitri M Drekonja, Jonathan D Alpern
Open Forum Infectious Diseases|March 19, 2025
Characteristics of Clinics Offering Nontraditional Lyme Disease Therapies in Lyme Endemic States of the United StatesJason R Sakizadeh, Meghan K Rothenberger, Jonathan D Alpern
Plos Neglected Tropical Diseases|September 15, 2017
Access to benznidazole for Chagas disease in the United States-Cautious optimism?Jonathan D Alpern, Rogelio Lopez-Velez, William M Stauffer
The New England Journal of Medicine|November 13, 2014
High-cost generic drugs--implications for patients and policymakersJonathan D Alpern, William M Stauffer, Aaron S Kesselheim
The New England Journal of Medicine|February 12, 2015
High-cost generic drugs--implications for patients and policymakersAaron S Kesselheim, Jonathan D Alpern, William M Stauffer
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 3, 2022
Food and Drug Administration Approval of Artesunate for Severe Malaria: Enough to Achieve Best Practice?Christine M Thomas, William M Stauffer, Jonathan D Alpern
Annals of Internal Medicine|June 19, 2018
Hepatitis B Vaccination, Screening, and Linkage to CareJonathan D Alpern, Thomas M Leventhal, Nathan C Bahr
JAMA|August 8, 2020
COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides HyperinfectionWilliam M Stauffer, Jonathan D Alpern, Patricia F Walker
Pageof 6